1Gent M, Beaumont D, Blanchard J, Janzon L, Kusmierek JJE,Panak E, et al. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk ofischaemic events (CAPRIE)[J]. Lancet, 1996; 348:1 329-1 338
2Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European stroke prevention study 2. Dipyridamole and acetylsalicyclic acid in the secondary prevention of stroke[J].J Neurol Sci, 1996; 143(1-2): 1-13
3Bennett CL , Davidson CJ , Raisch DW , Weinberg PD ,Bennett RH, Feldman MD. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention[J]. Arch Iht Med, 1999;159(21 ): 2 524-2 528
4Chen Z, Sandercock P, Pan H, Counsell C, Collins R, Liu L, Xie JX, Warlow C, Peto R. Indications for early aspirin use in acute ischaemic stroke. A combined analysis of 40 000randomized patients from the Chinese Acute Stroke Trial and the International St
5De Schryver ELLM, on behalf of the European/Australian Stroke Prevention in R eversible Ischaemia Trial (ESPR IT )Group. Design of ESPRIT: an international randomised trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin
6BoersmaE , HarringtonRA , MolitemoDJ , White H ,Theroux P, Van de Weft F, de Torbal A, Aemstrong PW,Wallentiu LC, Wilcox RG, Simes J, Califf Rm, Topol EJ,Simoons ML. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a men-analysis of
7Topol EJ, Easton JD, Amarenco P, Califf R, Harrington R,Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Shuaib A, Koudstaal PJ, Theroux P, Van' de Weft F,Willerson JT, Chan R, Samules R, Ilson B, Granett J.Design of the blockade of the glycop
8Mehta SR, Yusuf S, Peters RJG, Bertrand ME, Lewis BS,Natarajan MK, Malmberg K, Rupprecht H, Zhao F,Chrolavisius S, Copland I, Fox KA. for the Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE)Investigators. Effects of pretreatment wit
9Steinhubl SR, Berger PB, MannJT III, Fry ET, Delago A,Wilmer C, Topol EJ. for the CREDO Invesrgators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized controlled trial[J]. JAMA, 2002; 288:2 411-
10The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-Segment elevation[J]. N Engl J Med, 2001; 345(7) :494-502
7Antithrombotic Trialists′ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002, 324:71 -86.
8Warlow C, Dennis M, van Gijn J, et al, eds. Stroke: A Practical Guide to Management. 2nd ed. Oxford: Blackwell Science Ltd,2001.4 -27.
9Antiplatelet Trialists′ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. Ⅰ. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ, 1994, 308:81 -106.
10Gubitz G, Sandercock P, Counsell C. Antiplatelet therapy for acute ischaemic stroke (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Oxford: Update Software.
